# Norgine

Source: https://onco.cc/companies/norgine/  
OnCo record `norgine` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Norgine is a European specialty pharmaceutical company, founded in 1906 and based in Amsterdam, best known in cancer care for bowel preparations used before colonoscopy and for in-licensed cancer medicines.

## Summary

Norgine is a privately held European pharmaceutical company headquartered in Amsterdam with a history going back to 1906. It markets gastroenterology and supportive-care products, including bowel-cleansing preparations used ahead of colonoscopy and colorectal cancer screening, and licenses oncology medicines for Europe and Australia. It appears on ClinicalTrials.gov as lead sponsor of phase 3 trials in cancer settings.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Norgine B.V.; Norgine Ltd; Norgine Pharmaceuticals
- Tags: ctgov-sponsor
- HQ: Amsterdam
- Type: pharma
- Website: https://www.norgine.com

## Sources

- Official website: https://www.norgine.com
- ClinicalTrials.gov: trials led by Norgine: https://clinicaltrials.gov/search?lead=Norgine
- Wikidata: https://www.wikidata.org/wiki/Q97041850

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- technologies: [Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood)](https://onco.cc/technologies/colorectal-screening/)

---
JSON: https://onco.cc/api/v1/entities/norgine.json